Hormonal
Tirzepatide treatment significantly improves health-related quality of life (HRQoL) across physical, mental, and psychosocial domains in adults with obesity or overweight, with improvements generally scaling with the magnitude of weight loss.
If you have obesity or overweight and have struggled to lose weight through lifestyle changes alone, adding tirzepatide (after achieving initial loss via diet/exercise) can significantly boost your quality of life. This isn't just about weight; it's about better physical function, less pain, and improved mental health. The more weight you lose, the more your quality of life improves, especially if you had physical limitations before starting.
Tirzepatide was associated with significantly larger improvements than placebo in most HRQoL measures from randomization to 72 weeks. Improvements in tirzepatide recipients were generally numerically larger in those who met greater weight reduction thresholds.
Why this rating
Phase 3, randomized, double-blind, placebo-controlled trial with a large sample size (N=579 randomized) and robust statistical analysis.
Source
Tirzepatide and health‐related quality of life in adults with obesity or overweight: Results from the <scp>SURMOUNT</scp> ‐3 phase 3 randomized trial
Theresa Hunter et al. · Diabetes Obesity and Metabolism · 2025
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →